<--- Back to Details
First PageDocument Content
Immunosuppressants / Clinical research / Monoclonal antibodies / Autoimmune diseases / Design of experiments / Anakinra / Infliximab / TNF inhibitor / Adalimumab / Etanercept / Biopharmaceutical / Psoriatic arthritis
Immunosuppressants
Clinical research
Monoclonal antibodies
Autoimmune diseases
Design of experiments
Anakinra
Infliximab
TNF inhibitor
Adalimumab
Etanercept
Biopharmaceutical
Psoriatic arthritis

RHEUMATOLOGY Rheumatology 2011;50:iv5–iv9 doi:rheumatology/ker241 Indirect and mixed treatment comparisons in arthritis

Add to Reading List

Source URL: rheumatology.oxfordjournals.org

Download Document from Source Website

File Size: 96,11 KB

Share Document on Facebook

Similar Documents

UCB Presents Latest Research from Immunology Portfolio at American College of Rheumatology Annual Meeting Data presentations include:  Positive results from Period 1 of the C-EARLY™ Phase 3 study of CIMZIA® (certol

UCB Presents Latest Research from Immunology Portfolio at American College of Rheumatology Annual Meeting Data presentations include:  Positive results from Period 1 of the C-EARLY™ Phase 3 study of CIMZIA® (certol

DocID: 1rakB - View Document

JUNE 2015 TABLE OF CONTENTS  INTRODUCTION

JUNE 2015 TABLE OF CONTENTS INTRODUCTION

DocID: 1qDC6 - View Document

TABLE OF CONTENTS  INTRODUCTION 2

TABLE OF CONTENTS INTRODUCTION 2

DocID: 1qs3R - View Document

TABLE OF CONTENTS  INTRODUCTION 2

TABLE OF CONTENTS INTRODUCTION 2

DocID: 1qius - View Document

FEBRUARY 2015 TABLE OF CONTENTS  INTRODUCTION

FEBRUARY 2015 TABLE OF CONTENTS INTRODUCTION

DocID: 1qcKs - View Document